A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells
Ueno, Takayuki, Masuda, Norikazu, Kamigaki, Shunji, Morimoto, Takashi, Akiyama, Futoshi, Kurosumi, Masafumi, Tsuda, Hitoshi, Mikami, Yoshiki, Tanaka, Sunao, Morita, Satoshi, Toi, MasakazuLanguage:
english
Journal:
Cancer Medicine
DOI:
10.1002/cam4.1516
Date:
May, 2018
File:
PDF, 322 KB
english, 2018